GOLDMAN SACHS GROUP INC - CAPRICOR THERAPEUTICS INC ownership

CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B309. A total of 26 filers reported holding CAPRICOR THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CAPRICOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83,958
-28.5%
24,5490.0%0.00%
Q2 2023$117,344
+12.9%
24,549
-0.3%
0.00%
Q1 2023$103,913
+9.5%
24,624
+0.1%
0.00%
Q4 2022$94,933
-36.7%
24,594
-1.5%
0.00%
Q3 2022$150,000
+72.4%
24,964
+0.1%
0.00%
Q2 2022$87,000
-40.0%
24,949
-40.9%
0.00%
Q1 2022$145,000
+62.9%
42,238
+38.9%
0.00%
Q4 2021$89,0000.0%30,417
+37.4%
0.00%
Q3 2021$89,000
-50.3%
22,138
-43.0%
0.00%
Q2 2020$179,00038,8080.00%
Other shareholders
CAPRICOR THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 10,894$57,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 16,125$85,0000.00%
Cordasco Financial Network 310$2,0000.00%
Cutler Group LLC / CA 3,727$19,0000.00%
HAP Trading, LLC 23,800$25,0000.00%
JANE STREET GROUP, LLC 12,943$68,0000.00%
UBS Group AG 1,900$10,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 4,000$21,0000.00%
US BANCORP \DE\ 7,462$39,0000.00%
WELLS FARGO & COMPANY/MN 121$1,0000.00%
View complete list of CAPRICOR THERAPEUTICS INC shareholders